Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_4
4
31%
Ph not_applicable
7
54%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(11)
Other(2)

Detailed Status

Completed11
unknown2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 44 (33.3%)
N/A7 (58.3%)

Trials by Status

completed1185%
unknown215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13